Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

Graham SM, Holte SE, Peshu NM, Richardson BA, Panteleeff DD, Jaoko WG, Ndinya-Achola JO, Mandaliya KN, Overbaugh JM, McClelland RS.

AIDS. 2007 Feb 19;21(4):501-7.

PMID:
17301569
2.

High levels of cervical HIV-1 RNA during early HIV-1 infection.

Lavreys L, Baeten JM, Panteleeff DD, Richardson BA, McClelland RS, Chohan V, Mandaliya K, Ndinya-Achola JO, Overbaugh J.

AIDS. 2006 Nov 28;20(18):2389-90.

PMID:
17117027
3.

Subtype C Is associated with increased vaginal shedding of HIV-1.

John-Stewart GC, Nduati RW, Rousseau CM, Mbori-Ngacha DA, Richardson BA, Rainwater S, Panteleeff DD, Overbaugh J.

J Infect Dis. 2005 Aug 1;192(3):492-6. Epub 2005 Jun 23.

4.

The effect of hormonal contraception on genital tract shedding of HIV-1.

Wang CC, McClelland RS, Overbaugh J, Reilly M, Panteleeff DD, Mandaliya K, Chohan B, Lavreys L, Ndinya-Achola J, Kreiss JK.

AIDS. 2004 Jan 23;18(2):205-9.

PMID:
15075537
5.

Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women.

Lavreys L, Baeten JM, Kreiss JK, Richardson BA, Chohan BH, Hassan W, Panteleeff DD, Mandaliya K, Ndinya-Achola JO, Overbaugh J.

J Infect Dis. 2004 Jan 15;189(2):303-11. Epub 2004 Jan 9.

PMID:
14722896
6.

Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments.

Mbori-Ngacha D, Richardson BA, Overbaugh J, Panteleeff DD, Nduati R, Steele M, John-Stewart G.

J Virol. 2003 Jul;77(13):7702-5.

7.

Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection.

Richardson BA, Mbori-Ngacha D, Lavreys L, John-Stewart GC, Nduati R, Panteleeff DD, Emery S, Kreiss JK, Overbaugh J.

J Virol. 2003 Jun;77(12):7120-3.

8.

Virus load during primary Human Immunodeficiency Virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women.

Lavreys L, Baeten JM, Overbaugh J, Panteleeff DD, Chohan BH, Richardson BA, Mandaliya K, Ndinya-Achola JO, Kreiss JK.

Clin Infect Dis. 2002 Jul 1;35(1):77-81. Epub 2002 Jun 3.

PMID:
12060878
9.

Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.

Mcclelland RS, Wang CC, Mandaliya K, Overbaugh J, Reiner MT, Panteleeff DD, Lavreys L, Ndinya-Achola J, Bwayo JJ, Kreiss JK.

AIDS. 2001 Jan 5;15(1):105-10.

PMID:
11192850
10.

Effect of intrauterine device use on cervical shedding of HIV-1 DNA.

Richardson BA, Morrison CS, Sekadde-Kigondu C, Sinei SK, Overbaugh J, Panteleeff DD, Weiner DH, Kreiss JK.

AIDS. 1999 Oct 22;13(15):2091-7.

PMID:
10546862
11.

Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya.

Neilson JR, John GC, Carr JK, Lewis P, Kreiss JK, Jackson S, Nduati RW, Mbori-Ngacha D, Panteleeff DD, Bodrug S, Giachetti C, Bott MA, Richardson BA, Bwayo J, Ndinya-Achola J, Overbaugh J.

J Virol. 1999 May;73(5):4393-403.

12.

Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA.

Panteleeff DD, John G, Nduati R, Mbori-Ngacha D, Richardson B, Kreiss J, Overbaugh J.

J Clin Microbiol. 1999 Feb;37(2):350-3.

Supplemental Content

Loading ...
Support Center